QA Infrastructure & Facilities: QA infrastructure includes offices for documentation, deviation management, and product release, ensuring compliance, record-keeping, and batch certification.
Quality Systems & Procedures: Quality systems include SOPs, GMP compliance, batch record review, GDP, and internal audits to ensure accuracy, consistency, and regulatory adherence.
Quality Control (QC) Coordination & Validation & Qualification: QA ensures QC coordination through material testing, IPQC, and product testing while overseeing validation of processes, methods, cleaning, and equipment qualification.
Regulatory & Compliance Affairs / Stability & Product Monitoring: Regulatory affairs handle product filings, audits, pharmacovigilance, stability studies, and annual reviews to ensure compliance and quality monitoring.

Risk Management & CAPA / Training & Personnel Development: Risk management involves deviation investigation, change control, risk assessment, while training programs and QA awareness promote continuous improvement and compliance.
Ensuring Excellence, Delivering Trust – Quality First, Always!
Taj Pharma’s Quality Assurance (QA) Department plays a crucial role in ensuring the highest standards of quality, safety, and compliance in pharmaceutical manufacturing. The QA infrastructure includes a documentation room for maintaining essential records, a change control and deviation management area for handling process deviations, and a product release section to ensure batch compliance before market release.
The company follows stringent quality systems and procedures, including comprehensive Standard Operating Procedures (SOPs), adherence to Good Manufacturing Practices (GMP), and rigorous Batch Manufacturing and Packaging Record (BMR/BPR) reviews. Additionally, Good Documentation Practices (GDP) ensure traceable and accurate records, while regular internal audits maintain continuous improvement.
Taj Pharma coordinates closely with the Quality Control (QC) team to ensure all raw materials and finished products meet strict quality criteria. In-Process Quality Control (IPQC) monitors critical process parameters, while finished product testing ensures compliance with pharmacopeial standards.
The company employs robust validation and qualification protocols for processes, analytical methods, and equipment, ensuring manufacturing consistency and product quality. Regulatory and compliance affairs are managed by a dedicated team to handle regulatory filings and audits from global authorities such as the FDA and WHO, as well as pharmacovigilance to monitor adverse drug reactions.
With a strong focus on risk management and Corrective and Preventive Actions (CAPA), Taj Pharma continuously assesses and mitigates potential risks to product quality. The company also prioritizes training programs to ensure personnel are well-equipped with the latest GMP standards and industry knowledge.
Taj Pharma’s QA department ensures regulatory compliance and product excellence, reinforcing the company’s commitment to producing safe, effective, and high-quality pharmaceutical